India has the greatest number of tuberculosis (TB) cases in the world and it is estimated that more than three Lakh died of TB in 2023, according to scientists.
A two-day report (Regional Prospective Observational Research for Tuberculosis)-Indian India 14Th The annual meeting begged in the CSIR-Centre for cell and molecular biology (CCMB) to discuss preventive and diagnostic measures and new vaccines, here on Thursday.
Around 115 scientists, doctors and epidemiologists of India and the United States, all part of the Indian report consortium are participating to understand how immune systems act differently in patients with TB of different ages or the region in their respective bodies.
“We observe TB focused on germs. But we must observe the disease in a manner focused on people, such as their susceptibility, immunity and access to diagnosis and therapeutics. Address.
The one required to have a rural cohort or patients for TB evaluation studies to help study the effects of varying factors such as comorbidities caused by diabetes, anemia and nutrition of bad. “It is imperative that biologists work in close collaboration with doctors and public health researchers to address the TB challenge. This meeting is a reminder so that fundamental biologists contribute tangible to the diagnosis of diseases, Therapeutics K.
“Report India is a solid example for the commitment and integrity of TB researchers to combat the disease through intensive research through a national strategic plan,” said Senbagavalli Prakash Babu program manager, a press release said.
Published – April 10, 2025 09:30 PM IST